US OptionsDetailed Quotes

AORT250117P25000

Watchlist

0.75
0.000.00%

15min DelayTrading Nov 14 09:30 ET

0.00High0.00Low

Artivion Stock Discussion

Moomoo AI

Jan 18, 2024 15:10

Artivion's management optimizes capital structure for a new phase of profitable growth. Strong conviction in business outlook, recent financial performance and clinical data readouts expected to deliver significant shareholder value.

Press Release: Artivion Obtains $350 Million in Senior Secured Credit Facilities

Moomoo AI

Nov 6, 2023 12:48

Artivion's reinvestment has not significantly improved sales, resulting in a 52% decline in stock over the past five years. The market perspective shows skepticism, implying Artivion may not have substantial growth potential.

Here's What's Concerning About Artivion's (NYSE:AORT) Returns On Capital

Moomoo Breakfast US

Sep 23, 2022 07:59

Columns Today's Pre-Market Stock Movers: QCOM, BA, ROKU, AZN and More

Gapping up
In reaction to earnings/guidance:
• $CalAmp (CAMP.US)$ +0.6%
Other news:
• $Cano Health (CANO.US)$ +6.1% ( $Humana (HUM.US)$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics (CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial (LPLA.US)$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona (XRAY.US)$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX.US)$ +2.9% (tr...

No comment yet